The lawsuit, spearheaded by the Rosen Law Firm, claims that Insulet failed to disclose significant defects in its manufacturing processes. According to the filing, these oversights created a heightened risk that company products would violate safety regulations or potentially cause injury. When these issues became public, shareholders allegedly suffered financial losses due to the company's prior misleading statements.

Investors currently have the option to join the class action or remain absent members until a class is certified. Retaining individual counsel or proceeding through the firm are both viable paths, as serving as a lead plaintiff is not a prerequisite for sharing in a potential future recovery. Those interested in assuming a leadership role in the litigation must formally move the court by the August 31 deadline.